DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

1832 Repka-Ramirez MS, Baraniuk JN. Histamine in health and disease.
Clin Allergy Immunol, 2002, 17:1–25.
Reynolds NJ, Al-Daraji WI. Calcineurin inhibitors and sirolimus:
Mechanisms of action and applications in dermatology. Clin
Exp Dermatol, 2002, 27:555–561.
Richardson S, Gelfand J. Immunobiologicals, cytokines, and
growth factors in dermatology. In: Wolff K, Goldsmith LA, Katz
SI, et al., eds. Fitzpatrick’s Dermatology in General Medicine,
7th ed. New York, McGraw-Hill, 2008, pp. 2223–2231.
Rigel DS. The effect of sunscreen on melanoma risk. Dermatol
Clin, 2002, 20:601–606.
Salasche S, Shumack S. A review of imiquimod 5% cream for
the treatment of various dermatological conditions. Clin Exp
Dermatol, 2003, 28(suppl):1–3.
Sami N, Harper JC. Topical retinoids. In: Woverton SE, ed.
Comprehensive Dermatologic Drug Therapy, 2nd ed.
Philadelphia, Saunders, 2007, pp. 625–641.
Saporito FC, Menter MA. Methotrexate and psoriasis in the era
of new biologic agents. J Am Acad Dermatol, 2004,
50:301–309.
Sherman SI. Etiology, diagnosis, and treatment recommendations
for central hypothyroidism associated with bexarotene
therapy for cutaneous T-cell lymphoma. Clin Lymphoma,
2003, 3:249–252.
Sigmundsdottir H, Johnston A, Gudjonsson JE, et al.
Methotrexate markedly reduces the expression of vascular E-
selectin, cutaneous lymphocyte-associated antigen and the
numbers of mononuclear leucocytes in psoriatic skin. Exp
Dermatol, 2004, 13:426–434.
Silvis NG. Antimetabolites and cytotoxic drugs. Dermatol Clin,
2001, 19:105–118.
Smith DI, Swamy PM, Heffernan MP. Off-label uses of biologics
in dermatology: Interferon and intravenous immunoglobulin
(part 1 of 2). J Am Acad Dermatol, 2007, 56:e1–e54.
Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of
pruritus: Cutaneous elicitation of itch. Arch Dermatol, 2003,
139:1463–1470.
Stern RS. Psoralen and ultraviolet A light therapy for psoriasis.
N Engl J Med, 2007, 357:682–690.
Sukhatme SV, Gottlieb AB. Pediatric psoriasis: Updates in biologic
therapies. Dermatol Ther, 2009, 22:34–39.
SECTION IX
SPECIAL SYSTEMS PHARMACOLOGY
Tan HH. Antibacterial therapy for acne: A guide to selection and
use of systemic agents. Am J Clin Dermatol, 2003, 4:307–314.
Thomas K, Ruetter A, Luger TA. Intravenous immunoglobulin
therapy. In: Woverton SE, ed. Comprehensive Dermatologic
Drug Therapy, 2nd ed. Philadelphia, Saunders, 2007, pp.
459–469.
Tzu J, Kerdel F. From conventional to cutting edge: The new era
of biologics in treatment of psoriasis. Dermatol Ther, 2008,
21:131–141.
U.S. Food and Drug Administration (FDA). FDA Public Health
Advisory: Safety of Topical Lindane Products for the
Treatment of Scabies and Lice. Center for Drug Evaluation and
Research, U.S. Food and Drug Administration, Rockville,
MD, 2003.
Vahlquist A, Kuenzli S, Saurat J. Retinoids. In, Wolff K,
Goldsmith LA, Katz SI, et al., eds. Fitzpatrick’s Dermatology
in General Medicine, 7th ed. New York, McGraw-Hill, 2008,
pp. 2181–2186.
Wang Y. The functional regulation of TRPV1 and its role in pain
sensitization. Neurochem Res, 2008, 33:2008–2012.
Warren RB, Smith RL, Campalani E, et al. Genetic variation in
efflux transporters influences outcome to methotrexate therapy
in patients with psoriasis. J Invest Dermatol, 2008,
128:1925–1929.
Weinberg JM. An overview of infliximab, etanercept, efalizumab,
and alefacept as biologic therapy for psoriasis. Clin
Ther, 2003, 25:2487–2505.
Wines NY, Cooper AJ, Wines MP. Thalidomide in dermatology.
Aust J Dermatol, 2002, 45:229–240.
Winterfield L, Cather J, Cather J, Menter A. Changing paradigms
in dermatology: Nuclear hormone receptors. Clin Dermatol,
2003, 21:447–454.
Wolff K, Goldsmith LA, Katz SI, et al. Fitzpatrick’s
Dermatology in General Medicine, 7th ed. New York,
McGraw-Hill, 2008.
Zacheim HS, Epstein EH Jr, Crain WR. Topical carmustine
(BCNU) for cutaneous T cell lymphoma; a 15-year experience
in 143 patients. J Am Acad Dermatol, 1990, 22:802–810.
Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology:
Overview and update. J Am Acad Dermatol, 2001, 45:420–434.